FFTP Adipotide Vial

FFTP Adipotide is a modified peptide compound developed for scientific and laboratory investigation. In research settings, it is commonly explored in studies relating to adipose tissue biology and peptide-targeted mechanisms. Its unique peptide sequence makes it a widely recognised compound within experimental peptide research environments.

Chemical reference information: Molecular formula: C₁₁₁H₂₀₄N₃₆O₂₈S₂; Molecular weight: 2555.2 g/mol; Sequence: CKGGRAKDC-GG-D(KLAKLAK)₂. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

FFTP Adipotide 5 mg is offered as a NORVEXA research vial. The selected strength refers to the compound content of this vial reference. Request the matching batch record for identity, analytical specifications, and presentation details.

Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.

Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.

NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.

Molecular formula

C₁₁₁H₂₀₄N₃₆O₂₈S₂

Molecular weight

2555.2 g/mol

Sequence

CKGGRAKDC-GG-D(KLAKLAK)₂

Include the printed batch reference when requesting your certificate of analysis. The record applies to the batch supplied to your laboratory.